174 related articles for article (PubMed ID: 35726691)
1. Correlation of dehydroepiandrosterone with diabetic nephropathy and its clinical value in early detection.
Ma Y; Wang Q; Chen Y; Su J; Gao Q; Fan Y; Feng J; Liu M; He Q
J Diabetes Investig; 2022 Oct; 13(10):1695-1702. PubMed ID: 35726691
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
Zhai Y; Cao X; Liu S; Shen Y
Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
[TBL] [Abstract][Full Text] [Related]
3. Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study.
Liu L; Xia R; Song X; Zhang B; He W; Zhou X; Li S; Yuan G
J Diabetes Investig; 2021 Apr; 12(4):557-565. PubMed ID: 33319507
[TBL] [Abstract][Full Text] [Related]
4. [Can urine albumin/creatinine ratio replace 24 hours urinary albumin?].
Liu R; Zhu H; Yang JH; Gao ZA; Yuan XX; Li XC; Wang JY; Chang BC
Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):377-381. PubMed ID: 31060147
[No Abstract] [Full Text] [Related]
5. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
7. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
8. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
9. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
10. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
[TBL] [Abstract][Full Text] [Related]
11. Platelet-to-albumin ratio is a potential biomarker for predicting diabetic nephropathy in patients with type 2 diabetes.
Cao SL; Zhang GQ; Li J; Bao L; Lan XM; Jin QP; Luo HY; E J; Li B; Ma D; Bao X; Zheng YL
Biomark Med; 2023 Oct; 17(20):841-848. PubMed ID: 38180339
[No Abstract] [Full Text] [Related]
12. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-lymphocyte ratio is a valuable predictor for diabetic nephropathy in patients with type 2 diabetes.
Huang Q; Wu H; Wo M; Ma J; Fei X; Song Y
Medicine (Baltimore); 2020 May; 99(19):e20190. PubMed ID: 32384513
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
15. Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus.
Wang X; Yang W; Zhu Y; Zhang S; Jiang M; Hu J; Zhang HH
Front Endocrinol (Lausanne); 2022; 13():896511. PubMed ID: 35846305
[TBL] [Abstract][Full Text] [Related]
16. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
[No Abstract] [Full Text] [Related]
17. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
18. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.
Jiang Y; Li J; Zhang J; Chen S
Front Endocrinol (Lausanne); 2023; 14():1274025. PubMed ID: 38075072
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of lymphocyte count in autoimmune diabetic nephropathy.
Xiang Z; Liu W; Fu S; Hu J; Yang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1639-1649. PubMed ID: 38432854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
